ADHD Medication: A Comprehensive Guide for Parents

Most families whose child receives an ADHD diagnosis arrive with the same sentence: "I don't want to give medication." The hesitation is understandable. The noise online feeds parental anxiety with terms like "a drug", "addictive", "turns the child into a robot".

This article sets out what needs to be known about ADHD medication on an evidence basis: how the medicines work, which side effects occur and how they are managed, whether they are addictive, how long they are taken, and what can be done besides medication.

The aim is not to persuade you to use medication but to let you make your decision with accurate information. Choosing not to medicate is also legitimate, but that choice has consequences too, and both sides need to be known.

Key Points

• Medication is not the only treatment for ADHD; it runs alongside behavioural parent training, school adjustments and, where needed, therapy.
• Stimulants are among the best-evidenced treatments in ADHD and produce marked improvement in most children.
• Stimulants used under specialist supervision in a diagnosed child are not addictive. On the contrary, untreated ADHD increases the later risk of substance use.
• The most common side effects are reduced appetite and delayed sleep onset; both are largely manageable through dose and timing adjustments.
• Medication does not change personality. If a child appears "flattened", the dose is too high and needs adjusting.

When Is Medication Considered?

The decision is not made automatically the moment a diagnosis is given. What is decisive is not the presence of symptoms but the degree of functional impairment.

In children under six, the first-line approach is behavioural parent training; medication is considered only where that proves insufficient and symptoms markedly impair functioning.

In school-age children the picture differs. Where symptoms clearly affect academic achievement, peer relationships and self-esteem, medication is recommended alongside behavioural approaches.

How Is the Decision Made?

The decision rests on three components: severity of symptoms, loss of functioning, and the family's informed preference. The child's own view is brought into the process in an age-appropriate way.

At Assoc. Prof. Mehtap Eroglu's practice in Ankara, this decision is not taken in a single appointment; the family is given time to think and to ask questions.

How Do ADHD Medications Work?

In ADHD there is insufficient dopamine and noradrenaline transmission in the brain regions responsible for attention, impulse control and planning — particularly the prefrontal cortex.

Medication regulates that transmission. It does not sedate or dull the child; it enables the brain to do what it is already trying to do. A child on an appropriate dose therefore appears not "dulled" but more collected.

Two Main Groups

Stimulants: Methylphenidate and amphetamine derivatives. This is the most effective group and the first choice. The effect starts quickly — usually from the first day.

Non-stimulants: Medicines such as atomoxetine and guanfacine. Their effect begins more slowly (over some weeks) but is continuous through the day. They are preferred where stimulants are not tolerated, or where tic disorder or marked anxiety is present.

Short- and Long-Acting Forms

The short-acting form of stimulants works for three to four hours, the long-acting form for eight to twelve. Long-acting forms cover the school day, so a single daily dose suffices; this removes the need to take medication at school and protects the child's privacy.

How Is the Dose Determined?

With ADHD medication, the dose is not calculated automatically from the child's weight. Each child responds differently, so treatment starts low and increases gradually.

The target is the dose that gives the best improvement in symptoms with the fewest side effects. Reaching that point can take several weeks, and during that time the family's feedback is decisive: at what times the effect begins, when it wears off, what has changed at school and at home.

Keeping brief daily notes during the early period — sleep, appetite, time spent on homework, number of outbursts — therefore makes dose adjustment markedly easier.

Side Effects and Their Management

Most side effects appear in the first weeks, are dose-related and manageable.

Reduced Appetite

The most common side effect. The child does not feel hungry during the hours the medication is active.

Management: Having breakfast before the dose, moving dinner to after the effect has worn off, offering small high-calorie snacks during the day. Weight and height are monitored at every review; if there is marked deviation from the growth curve, the dose is reconsidered or a medication break is discussed.

Delayed Sleep Onset

The second most common side effect.

Management: Moving the dose earlier, giving the long-acting form at an earlier hour, limiting evening screen use and improving sleep hygiene. These adjustments are sufficient in most cases.

Headache and Abdominal Pain

Usually seen in the first days and resolves spontaneously. Taking the medication with food and increasing fluid intake during the day helps.

Rebound

As the medication wears off, usually in the late afternoon, there may be a temporary increase in symptoms and restlessness. Switching to a long-acting form or a small additional afternoon dose manages this.

Mood Changes

Some children may become tearful, irritable or withdrawn. If a child appears flat, unresponsive or "not themselves", this is a side effect and must be reported. The correct dose does not change a child's personality.

Tics

Existing tics may increase with medication. Non-stimulant options may be preferred in children with tic disorder.

Pulse and Blood Pressure

Stimulants can slightly raise pulse and blood pressure; in most children this increase is not clinically meaningful, but it is still monitored. A history of heart disease and of sudden death in the family is therefore explored before treatment, and pulse and blood pressure are measured at reviews.

The Most Common Concerns

"Is It Addictive?"

No. Stimulants used in a diagnosed child, under specialist supervision, orally and at the recommended dose are not addictive.

Moreover, research shows the opposite: the later risk of substance use is lower in treated ADHD than in untreated ADHD. Untreated ADHD is itself a factor that raises that risk, through impulsivity and problems with self-esteem.

"Will It Change My Child's Personality?"

No. At an appropriate dose, medication leaves the child calmer but the same child. Their humour, cheerfulness and interests remain.

If a child has become flat, speaks less or shows reduced emotional response, that is a sign of too high a dose and should be corrected. It is a side effect, not an inevitable consequence of treatment.

"What If We Forget a Dose?"

Stimulants do not accumulate in the body; their effects begin and end within the day they are taken. Missing a dose is not dangerous; symptoms simply return to baseline that day.

A missed dose noticed late in the day should not be taken, as it will disrupt sleep. The usual routine resumes the next day.

Non-stimulants are different: they work through regular use, and missed doses reduce their effectiveness.

"Will It Stunt Growth?"

A slight slowing of growth has been reported with long-term stimulant use; the effect is small and generally reversible. Height and weight are therefore measured at every review and the growth curve monitored.

Where marked deviation appears, the dose is reduced, the medication changed, or a break planned.

"Will They Take It for Life?"

No. The duration of treatment is set according to symptoms and functioning and reviewed annually. In some children symptoms decrease in adolescence and medication can be stopped; in others it continues into adulthood.

The decision is made afresh each year; starting does not mean continuing forever.

What to Do If a Side Effect Occurs

Medication should not be stopped on your own. Most side effects can be managed through changes of dose, timing or formulation; stopping is usually not necessary.

Situations requiring immediate report: chest pain, palpitations, fainting, visual changes, extreme restlessness, serious mood changes, or thoughts of self-harm.

Other side effects can be addressed at the next review; but if they markedly affect the child's daily life, do not wait.

Is Medication Enough on Its Own?

No. Research shows the best outcomes where medication and behavioural approaches are combined.

Medication improves attention and impulse control, but it does not teach skills. Establishing homework routines, time management, organisation and social skills must be worked on separately.

Behavioural Parent Training

Develops the family's skills in setting consistent limits, reinforcing positive behaviour and managing conflict without escalation. It is an indispensable component of ADHD treatment.

School Adjustments

Collaboration with teachers, seating arrangements, breaking instructions into steps, extra time and visual reminders directly support academic functioning. Contact with school is part of treatment.

Treating Co-occurring Conditions

ADHD is often not seen alone. Learning disorder, anxiety disorder, oppositional defiant disorder, sleep disorder and tic disorder frequently accompany it.

Missing these creates the impression that the ADHD medication "isn't working". For example, where an unrecognised learning disorder is present, academic performance will not improve even if attention does, and the family concludes the medication is ineffective.

The treatment plan must therefore cover not only ADHD but all accompanying conditions.

Sleep, Nutrition and Movement

Regular sleep and physical activity have a measurable positive effect on attention. These do not replace medication but support its effect.

Medication Breaks

A medication break means stopping at weekends or during the summer holiday. It is not routinely recommended and is assessed case by case.

Situations where it may be considered: Marked appetite reduction and slowed growth; symptoms that primarily affect the academic domain.

Situations where it is not appropriate: Where impulsivity and behavioural problems predominate, where there is accident risk, or where peer relationships are markedly affected. In these children symptoms persist at weekends and a break does harm.

The decision must be made with the clinician; families should not stop medication themselves. If a break is trialled, noting how symptoms behave during it makes the following year's decision better grounded.

Monitoring: How Often Are Reviews?

At Assoc. Prof. Mehtap Eroglu's practice in Ankara, reviews are frequent at the start of treatment; close monitoring is needed until the dose is settled. Once the picture stabilises, intervals lengthen.

Each review assesses: change in symptoms, height and weight, pulse and blood pressure, sleep and appetite, side effects, school feedback, and the child's own account.

Behaviour rating scales completed by family and teachers turn progress from subjective impression into something measurable. Repeating these regularly at follow-up in Ankara means dose decisions rest on data rather than estimation.

Treatment in Adolescence

Two new issues come to the fore in adolescence. The first is the young person's own decision: if an adolescent does not want to take medication, compulsion does not work. What the medication does should be discussed directly with them and they should be included in the decision.

The second is medication being given away or sold. Stimulants are controlled medicines and may be in demand among peers during examination periods. This should be discussed openly with the young person and access to the medication managed within the family.

It should also be known that when driving age arrives, untreated ADHD increases the risk of road traffic accidents; this is an important factor in the treatment decision.

How Should Medication Be Explained to the Child?

A child knowing why they are taking medication directly affects adherence. Concealing it, or calling it "a vitamin", damages trust when the child learns the truth.

The explanation should be age-appropriate and non-blaming. For a young child: "Your brain works very fast and sometimes it's hard to stop and think. This medicine helps with that, so you can do what you want to do more easily."

For a school-age child, the analogy of glasses for attention works: glasses make seeing easier but do not change the eye; medication makes gathering attention easier without changing the child.

The frame to avoid is presenting the medication as a punishment or a "naughtiness pill". That leads a child to see themselves as defective and to refuse it.

If the child needs to take medication at school, their privacy should be protected; this is one advantage of long-acting forms.

Expert Opinion

According to Assoc. Prof. Mehtap Eroglu, the situation encountered most often in ADHD medication referrals is a family trying to decide on the basis of information gathered online. That information usually consists of extreme examples and personal accounts; it does not substitute for evidence.

Clinical experience from consultations in Ankara shows that adherence increases markedly where families' concerns are discussed openly. What helps is not suppressing anxiety but naming it.

Assoc. Prof. Mehtap Eroglu also emphasises that the medication decision is not imposed on families. Where a family is not ready, work begins with behavioural approaches and the picture is monitored together. Medication is a decision a family is informed about, not persuaded into.

A further important point is that not treating is also a choice, and it too has consequences: academic failure, peer difficulties, low self-esteem and accident risk. The decision requires weighing not only the risks of medication but the risks of leaving ADHD untreated.

Assessment and Appointment Process in Ankara

A considerable proportion of referrals about ADHD medication in Ankara are for a second opinion after diagnosis elsewhere. That request is legitimate; one should be confident of the diagnosis before a medication decision.

In the assessment conducted by Assoc. Prof. Mehtap Eroglu in Ankara, the diagnosis is first reviewed: are symptoms seen in more than one setting, when did they begin, is there an accompanying learning disorder, anxiety disorder or sleep problem. Other conditions that can look like an attention problem are also excluded.

Where medication is considered, history of heart disease, sudden death in the family and tic history are explored; baseline height, weight, pulse and blood pressure are recorded.

What families in Ankara find useful to bring to the first appointment: the school observation form and teacher's view, school reports, any previous assessment reports and attention tests, and a list of current medications.

For your child's ADHD assessment and treatment plan in Ankara, you can review our child psychiatry service and request an appointment.

In Summary

ADHD medication is among the best-evidenced treatments, but it is not a solution on its own; it must run alongside behavioural parent training and school adjustments.

Stimulants used under specialist supervision are not addictive; untreated ADHD is itself a factor that raises the later risk of substance use.

The most common side effects are reduced appetite and delayed sleep onset; both can be managed through dose and timing. If a child becomes flat, that signals too high a dose rather than an inevitable consequence of treatment.

The decision is not imposed. It is made in an informed way, weighing the consequences both of medication and of leaving ADHD untreated, and reviewed each year. Starting does not mean continuing forever; stopping is a natural part of monitoring too.

For detailed information on ADHD symptoms, subtypes and the diagnostic process, see our ADHD guide.